Abstract: An apparatus for wirelessly connecting a smartphone to a remote FM radio system, for controlling playback of audio content delivered wirelessly to the smartphone via a wide area network, on the remote FM radio system. An apparatus housing receives a DC power signal from a remote DC power source. A control panel has a display and controls for controlling playback of the audio content on the remote FM radio system, at least one of the controls performing a function in common with a playback control appearing on a display of the smartphone. An electronic subsystem communicates with the control panel and wirelessly receives audio content from the smartphone, and communicates the audio content as an FM signal via a user playback command input at the controls of the control panel, to the remote FM radio system.

Abstract: A portable media player and a car media player are disclosed. In either implementation the media player may be used to record digital content as it is streamed over a wide area network (WAN). The recorded digital content may then be played back using the media player and associated controls on the media player. In one implementation the media player makes use of a stored program and an external computer so that digital content recorded by the computer may then transferred from the computer on to the media player for storage and playback.

Abstract: A wireless receiver and methods for storing content from RF signals received by the wireless receiver are provided. The wireless receiver includes a microprocessor and an RF receiver configured to operably communicate with the microprocessor. The RF receiver is configured to receive an RF signal having digital content therein. The wireless receiver further includes a detachable memory device configured to operably communicate with the microprocessor. The detachable memory device has a unique serial number stored therein. The microprocessor is configured to retrieve the unique serial number from the detachable memory device. The microprocessor is further configured to receive the digital content from the RF receiver and to encrypt the digital content utilizing the unique serial number to obtain encrypted digital content. The microprocessor is further configured to store the encrypted digital content on the detachable memory device.

Abstract: An apparatus for wirelessly connecting a smartphone to a remote FM radio system, for controlling playback of audio content delivered wirelessly to the smartphone via a wide area network, on the remote FM radio system. An apparatus housing receives a DC power signal from a remote DC power source. A control panel has a display and controls for controlling playback of the audio content on the remote FM radio system, at least one of the controls performing a function in common with a playback control appearing on a display of the smartphone. An electronic subsystem communicates with the control panel and wirelessly receives audio content from the smartphone, and communicates the audio content as an FM signal via a user playback command input at the controls of the control panel, to the remote FM radio system.

Abstract: A portable media player and a car media player are disclosed. In either implementation the media player may be used to record digital content as it is streamed over a wide area network (WAN). The recorded digital content may then be played back using the media player and associated controls on the media player. In one implementation the media player makes use of a stored program and an external computer so that digital content recorded by the computer may then transferred from the computer on to the media player for storage and playback.

Abstract: A wireless receiver and methods for storing content from RF signals received by the wireless receiver are provided. The wireless receiver includes a microprocessor and an RF receiver configured to operably communicate with the microprocessor. The RF receiver is configured to receive an RF signal having digital content therein. The wireless receiver further includes a detachable memory device configured to operably communicate with the microprocessor. The detachable memory device has a unique serial number stored therein. The microprocessor is configured to retrieve the unique serial number from the detachable memory device. The microprocessor is further configured to receive the digital content from the RF receiver and to encrypt the digital content utilizing the unique serial number to obtain encrypted digital content. The microprocessor is further configured to store the encrypted digital content on the detachable memory device.

Abstract: An oil-sorbing filter element for removing oil from an aqueous flow such as the bilge water of a watercraft. The element includes a first stage which is formed of a consolidated permeable mass of a oleophilic polymeric material such as styrenic mid-block copolymer.

Abstract: Haplotypes in the NTRK1 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK1 haplotypes are disclosed.

Abstract: Haplotypes in the LDLR gene associated: with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these LDLR haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these LDLR haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.

Abstract: Haplotypes in the APOE gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these APOE haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these APOE haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.

Abstract: Haplotypes in the LRPAP1 gene associated with cognitive response to galantamine treatment are disclosed. Compositions and methods for detecting and using these LRPAP1 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising galantamine or derivatives thereof that are approved for treating patients having one of these LRPAP1 haplotypes, methods and kits for predicting the response of an individual to galantamine based upon his/her haplotype profile, and methods for treating Alzheimer's patients based upon their haplotype profile.

Abstract: Haplotypes in the SLC5A7 gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these SLC5A7 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these SLC5A7 haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.

Abstract: Haplotypes in the APOC1 gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these APOC1 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these APOC1 haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.

Abstract: Haplotypes in the NTRK1 gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these NTRK1 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these NTRK1 haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.

Abstract: Haplotypes in the CDK5 gene associated with cognitive response to galantamine treatment are disclosed. Compositions and methods for detecting and using these CDK5 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising galantamine or derivatives thereof that are approved for treating patients having one of these CDK5 haplotypes, methods and kits for predicting the response of an individual to galantamine based upon his/her haplotype profile, and methods for treating Alzheimer's patients based upon their haplotype profile.

Abstract: Haplotypes in the CHRNA9 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these CHRNA9 haplotypes are disclosed.

Abstract: Haplotypes in the NTRK2 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK2 haplotypes are disclosed.

Abstract: Haplotypes in the EPHX2 gene associated with cognitive response to galantamine treatment are disclosed. Compositions and methods for detecting and using these EPHX2 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising galantamine or derivatives thereof that are approved for treating patients having one of these EPHX2 haplotypes, methods and kits for predicting the response of an individual to galantamine based upon his/her haplotype profile, and methods for treating Alzheimer's patients based upon their haplotype profile.

Abstract: Haplotypes in the APOA4 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these APOA4 haplotypes are disclosed.

Abstract: Novel genetic variants of the Fc Fragment Of Ige, High Affinity I, Receptor For; Alpha Polypeptide (FCER1A) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the FCER1A gene. Compositions and methods for haplotyping and/or genotyping the FCER1A gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.